Deals  |  Closed Deal

ICON advises Axis Three on £2m funding led by Crescent Capital with Clarendon Fund Managers and Siemens among the investors

Deal Release:

Current applications target the cosmetic surgery market ... future applications will target the medical podiatry/orthopedic sectors and 3D gaming animation

22 Aug 2009

ICON Corporate Finance advises Axis Three on its £2m funding round. The investment was led by Crescent Capital with Clarendon Fund Managers and Siemens among the investors who followed their money.

Axis Three creates the standard for predictive surgical simulation. By integrating patented image capture technology developed by Siemens, with its own innovative software, Axis Three delivers a paradigm shift in medical imaging: Precise surface anatomy capture, breakthrough simulation technology, interactive, photo-quality three dimensional (3D) models, and powerful tools that display post surgical results.

Current applications target the cosmetic surgery market and are available for the face and breast; however, future applications will target the medical podiatry/orthopedic sectors and 3D gaming animation.

The company will use the funding to accelerate sales and marketing and to develop software upgrades and new applications.

Axis Three has offices in Belfast, Northern Ireland and Boston, Massachusetts.

Key Facts:

Name

Axis Three

HQ

Belfast, Belfast, United Kingdom

Key People

Bryan Keating, Executive Chairman

ICON Team

Deal type

Date

2009

Client Comment:

I have been involved with fund raising with many companies over many years, quite often without external help. However, using ICON in our latest venture has been without doubt a revelation and a great asset in the whole process. They are "first class" partners to work with
Bryan Keating, Executive Chairman, Axis Three
Axis Three

Geography: